# SHEN ZHEN EVERGREEN BIO-HEALTH TECHNOLOGY · 99-39 · CHINA — FDA import alert red lists: firms subject to detention without physical examination

For SHEN ZHEN EVERGREEN BIO-HEALTH TECHNOLOGY · 99-39 · CHINA, import alert is 99-39; import alert name is Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded; country is CHINA; product is Chlorella 1000 Tablets (250g) dietary supplement | Chlorella Powder 8 oz dietary supplement | Chlorella 1000 Tablets (250g) dietary supplement | Chlorella Powder 8 oz dietary supplement | Chlorella 1000 Tablets (250g) dietary supplement; product code is 41 Y - - 99 Dietary Conventional Foods, N.E.C. | 41 Y - - 99 Dietary Conventional Foods, N.E.C. | 54 Y - - 03 Chlorella (tablet), Vit/Min/Protein/Unconventional Dietary Spec for Human/Animal, n.e.c.) | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C; date published is 09/12/2024; address is Block D Room 1105 , Longcheng Street , Shenzhen, CHINA, verified against its source on 2026-09-16.

- **Firm:** SHEN ZHEN EVERGREEN BIO-HEALTH TECHNOLOGY _(verified: appears in the quote below)_
- **Import alert:** 99-39
- **Import alert name:** Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded
- **Country:** CHINA _(verified: appears in the quote below)_
- **Address:** Block D Room 1105 , Longcheng Street , Shenzhen, CHINA _(verified: appears in the quote below)_
- **Date published:** 09/12/2024 _(verified: appears in the quote below)_
- **Product code:** 41 Y - - 99 Dietary Conventional Foods, N.E.C. | 41 Y - - 99 Dietary Conventional Foods, N.E.C. | 54 Y - - 03 Chlorella (tablet), Vit/Min/Protein/Unconventional Dietary Spec for Human/Animal, n.e.c.) | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. _(verified: each item appears in the quote below)_
- **Product:** Chlorella 1000 Tablets (250g) dietary supplement | Chlorella Powder 8 oz dietary supplement | Chlorella 1000 Tablets (250g) dietary supplement | Chlorella Powder 8 oz dietary supplement | Chlorella 1000 Tablets (250g) dietary supplement _(verified: each item appears in the quote below)_
- **FDA notes:** The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of: Section 403(q)(5)(F) of the Act [21 U.S.C. §343(q)(5)(F)] in that the presentation of the nutrition information on the labeling of your products do not comply with 21 CFR 101.36 and 21 CFR 101.9. Section 403(r)(1)(A) of the Act [21 U.S.C. §343(r)(1)(A)] in that the labeling of the article does not meet the requirements to bear the claims in accordance with the requirements under 21 CFR 101.54(b) and (c). Section 403(s)(2)(B) of the Act [21 U.S.C. §343(s)(2)(B)] in that the label fails to include a statement of identity as a “dietary supplement” on the principal display panel, except that the word “dietary” may be deleted and replaced by the name of the dietary ingredients in the product or an appropriately descriptive term indicating the type of dietary ingredients that are in the product [21 CFR 101.3(a), (b), and (g)]. Section 403(y) of the Act [21 U.S.C. §343(y)] in that the labels fail to bear a domestic address or domestic phone number through which the responsible person, as described in Section 761 of the Act [21 U.S.C. 379aa-1]. | The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of: Section 403(a)(1) of the Act [21 U.S.C. 343(a)(1)] in that the label is false or misleading. Section 403(q)(1)(A) of the Act [21 U.S.C. 343(q)(1)(A)] because the serving size declared on the label is incorrect. Section 403(q)(5)(F) of the Act [21 U.S.C. §343(q)(5)(F)] in that the presentation of the nutrition information on the labeling of your products do not comply with 21 CFR 101.36 and 21 CFR 101.9. Section 403(r)(1)(A) of the Act [21 U.S.C. §343(r)(1)(A)] in that the labeling of the article does not meet the requirements to bear the claims in accordance with the requirements under 21 CFR 101.54(b) and (c). Section 403(s)(2)(B) of the Act [21 U.S.C. §343(s)(2)(B)] in that the label fails to include a statement of identity as a “dietary supplement” on the principal display panel, except that the word “dietary” may be deleted and replaced by the name of the dietary ingredients in the product or an appropriately descriptive term indicating the type of dietary ingredients that are in the product [21 CFR 101.3(a), (b), and (g)]. Section 403(y) of the Act [21 U.S.C. §343(y)] in that the labels fail to bear a domestic address or domestic phone number through which the responsible person, as described in Section 761 of the Act [21 U.S.C. 379aa-1]. | The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of: Section 403(q)(5)(F) of the Act [21 U.S.C. §343(q)(5)(F)] in that the presentation of the nutrition information on the labeling of your products do not comply with 21 CFR 101.36 and 21 CFR 101.9. Section 403(r)(1)(A) of the Act [21 U.S.C. §343(r)(1)(A)] in that the labeling of the article does not meet the requirements to bear the claims in accordance with the requirements under 21 CFR 101.54(b) and (c). Section 403(s)(2)(B) of the Act [21 U.S.C. §343(s)(2)(B)] in that the label fails to include a statement of identity as a “dietary supplement” on the principal display panel, except that the word “dietary” may be deleted and replaced by the name of the dietary ingredients in the product or an appropriately descriptive term indicating the type of dietary ingredients that are in the product [21 CFR 101.3(a), (b), and (g)]. Section 403(y) of the Act [21 U.S.C. §343(y)] in that the labels fail to bear a domestic address or domestic phone number through which the responsible person, as described in Section 761 of the Act [21 U.S.C. 379aa-1]. | The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of: Section 403(a)(1) of the Act [21 U.S.C. 343(a)(1)] in that the label is false or misleading. Section 403(q)(1)(A) of the Act [21 U.S.C. 343(q)(1)(A)] because the serving size declared on the label is incorrect. Section 403(q)(5)(F) of the Act [21 U.S.C. §343(q)(5)(F)] in that the presentation of the nutrition information on the labeling of your products do not comply with 21 CFR 101.36 and 21 CFR 101.9. Section 403(r)(1)(A) of the Act [21 U.S.C. §343(r)(1)(A)] in that the labeling of the article does not meet the requirements to bear the claims in accordance with the requirements under 21 CFR 101.54(b) and (c). Section 403(s)(2)(B) of the Act [21 U.S.C. §343(s)(2)(B)] in that the label fails to include a statement of identity as a “dietary supplement” on the principal display panel, except that the word “dietary” may be deleted and replaced by the name of the dietary ingredients in the product or an appropriately descriptive term indicating the type of dietary ingredients that are in the product [21 CFR 101.3(a), (b), and (g)]. Section 403(y) of the Act [21 U.S.C. §343(y)] in that the labels fail to bear a domestic address or domestic phone number through which the responsible person, as described in Section 761 of the Act [21 U.S.C. 379aa-1]. | The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of: Section 403(q)(5)(F) of the Act [21 U.S.C. §343(q)(5)(F)] in that the presentation of the nutrition information on the labeling of your products do not comply with 21 CFR 101.36 and 21 CFR 101.9. Section 403(r)(1)(A) of the Act [21 U.S.C. §343(r)(1)(A)] in that the labeling of the article does not meet the requirements to bear the claims in accordance with the requirements under 21 CFR 101.54(b) and (c). Section 403(s)(2)(B) of the Act [21 U.S.C. §343(s)(2)(B)] in that the label fails to include a statement of identity as a “dietary supplement” on the principal display panel, except that the word “dietary” may be deleted and replaced by the name of the dietary ingredients in the product or an appropriately descriptive term indicating the type of dietary ingredients that are in the product [21 CFR 101.3(a), (b), and (g)]. Section 403(y) of the Act [21 U.S.C. §343(y)] in that the labels fail to bear a domestic address or domestic phone number through which the responsible person, as described in Section 761 of the Act [21 U.S.C. 379aa-1]. _(verified: each item appears in the quote below)_

## What the source says

> SHEN ZHEN EVERGREEN BIO-HEALTH TECHNOLOGY Date Published : 09/12/2024 Block D Room 1105 , Longcheng Street , Shenzhen, CHINA 41 Y - - 99 Dietary Conventional Foods, N.E.C. Date Published: 09/12/2024 Desc: Chlorella 1000 Tablets (250g) dietary supplement Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of: Section 403(q)(5)(F) of the Act [21 U.S.C. §343(q)(5)(F)] in that the presentation of the nutrition information on the labeling of your products do not comply with 21 CFR 101.36 and 21 CFR 101.9. Section 403(r)(1)(A) of the Act [21 U.S.C. §343(r)(1)(A)] in that the labeling of the article does not meet the requirements to bear the claims in accordance with the requirements under 21 CFR 101.54(b) and (c). Section 403(s)(2)(B) of the Act [21 U.S.C. §343(s)(2)(B)] in that the label fails to include a statement of identity as a “dietary supplement” on the principal display panel, except that the word “dietary” may be deleted and replaced by the name of the dietary ingredients in the product or an appropriately descriptive term indicating the type of dietary ingredients that are in the product [21 CFR 101.3(a), (b), and (g)]. Section 403(y) of the Act [21 U.S.C. §343(y)] in that the labels fail to bear a domestic address or domestic phone number through which the responsible person, as described in Section 761 of the Act [21 U.S.C. 379aa-1]. 41 Y - - 99 Dietary Conventional Foods, N.E.C. Date Published: 09/12/2024 Desc: Chlorella Powder 8 oz dietary supplement Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of: Section 403(a)(1) of the Act [21 U.S.C. 343(a)(1)] in that the label is false or misleading. Section 403(q)(1)(A) of the Act [21 U.S.C. 343(q)(1)(A)] because the serving size declared on the label is incorrect. Section 403(q)(5)(F) of the Act [21 U.S.C. §343(q)(5)(F)] in that the presentation of the nutrition information on the labeling of your products do not comply with 21 CFR 101.36 and 21 CFR 101.9. Section 403(r)(1)(A) of the Act [21 U.S.C. §343(r)(1)(A)] in that the labeling of the article does not meet the requirements to bear the claims in accordance with the requirements under 21 CFR 101.54(b) and (c). Section 403(s)(2)(B) of the Act [21 U.S.C. §343(s)(2)(B)] in that the label fails to include a statement of identity as a “dietary supplement” on the principal display panel, except that the word “dietary” may be deleted and replaced by the name of the dietary ingredients in the product or an appropriately descriptive term indicating the type of dietary ingredients that are in the product [21 CFR 101.3(a), (b), and (g)]. Section 403(y) of the Act [21 U.S.C. §343(y)] in that the labels fail to bear a domestic address or domestic phone number through which the responsible person, as described in Section 761 of the Act [21 U.S.C. 379aa-1]. 54 Y - - 03 Chlorella (tablet), Vit/Min/Protein/Unconventional Dietary Spec for Human/Animal, n.e.c.) Date Published: 09/12/2024 Desc: Chlorella 1000 Tablets (250g) dietary supplement Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of: Section 403(q)(5)(F) of the Act [21 U.S.C. §343(q)(5)(F)] in that the presentation of the nutrition information on the labeling of your products do not comply with 21 CFR 101.36 and 21 CFR 101.9. Section 403(r)(1)(A) of the Act [21 U.S.C. §343(r)(1)(A)] in that the labeling of the article does not meet the requirements to bear the claims in accordance with the requirements under 21 CFR 101.54(b) and (c). Section 403(s)(2)(B) of the Act [21 U.S.C. §343(s)(2)(B)] in that the label fails to include a statement of identity as a “dietary supplement” on the principal display panel, except that the word “dietary” may be deleted and replaced by the name of the dietary ingredients in the product or an appropriately descriptive term indicating the type of dietary ingredients that are in the product [21 CFR 101.3(a), (b), and (g)]. Section 403(y) of the Act [21 U.S.C. §343(y)] in that the labels fail to bear a domestic address or domestic phone number through which the responsible person, as described in Section 761 of the Act [21 U.S.C. 379aa-1]. 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. Date Published: 09/12/2024 Desc: Chlorella Powder 8 oz dietary supplement Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of: Section 403(a)(1) of the Act [21 U.S.C. 343(a)(1)] in that the label is false or misleading. Section 403(q)(1)(A) of the Act [21 U.S.C. 343(q)(1)(A)] because the serving size declared on the label is incorrect. Section 403(q)(5)(F) of the Act [21 U.S.C. §343(q)(5)(F)] in that the presentation of the nutrition information on the labeling of your products do not comply with 21 CFR 101.36 and 21 CFR 101.9. Section 403(r)(1)(A) of the Act [21 U.S.C. §343(r)(1)(A)] in that the labeling of the article does not meet the requirements to bear the claims in accordance with the requirements under 21 CFR 101.54(b) and (c). Section 403(s)(2)(B) of the Act [21 U.S.C. §343(s)(2)(B)] in that the label fails to include a statement of identity as a “dietary supplement” on the principal display panel, except that the word “dietary” may be deleted and replaced by the name of the dietary ingredients in the product or an appropriately descriptive term indicating the type of dietary ingredients that are in the product [21 CFR 101.3(a), (b), and (g)]. Section 403(y) of the Act [21 U.S.C. §343(y)] in that the labels fail to bear a domestic address or domestic phone number through which the responsible person, as described in Section 761 of the Act [21 U.S.C. 379aa-1]. 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. Date Published: 09/12/2024 Desc: Chlorella 1000 Tablets (250g) dietary supplement Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of: Section 403(q)(5)(F) of the Act [21 U.S.C. §343(q)(5)(F)] in that the presentation of the nutrition information on the labeling of your products do not comply with 21 CFR 101.36 and 21 CFR 101.9. Section 403(r)(1)(A) of the Act [21 U.S.C. §343(r)(1)(A)] in that the labeling of the article does not meet the requirements to bear the claims in accordance with the requirements under 21 CFR 101.54(b) and (c). Section 403(s)(2)(B) of the Act [21 U.S.C. §343(s)(2)(B)] in that the label fails to include a statement of identity as a “dietary supplement” on the principal display panel, except that the word “dietary” may be deleted and replaced by the name of the dietary ingredients in the product or an appropriately descriptive term indicating the type of dietary ingredients that are in the product [21 CFR 101.3(a), (b), and (g)]. Section 403(y) of the Act [21 U.S.C. §343(y)] in that the labels fail to bear a domestic address or domestic phone number through which the responsible person, as described in Section 761 of the Act [21 U.S.C. 379aa-1].

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_1144.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).